Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Electrophysiological correlates of COMT genotype and acute/chronic methylphenidate or atomoxetine treatment in ADHD
2008-001291-71Phase 4Active
- Sponsor
- University of Wuerzburg
- Start
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of atomoxetine and methylphenidate in attention deficit hyperactivity disorder (ADHD) (2 arms), sponsored by University of Wuerzburg. Primary endpoints: Neurophysiological measures at day 28, NGA and 1 more. Started Jun 2008; status: active.
02
Drugs
atomoxetinemethylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on 2008-001291-71.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001291-71.